Published in Eur J Pharmacol on February 19, 1982
Subclassification of release-regulating alpha 2-autoreceptors in human brain cortex. Br J Pharmacol (1992) 0.93
In vivo microdialysis of noradrenaline overflow: effects of alpha-adrenoceptor agonists and antagonists measured by cumulative concentration-response curves. Br J Pharmacol (1993) 0.86
Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Br J Pharmacol (1991) 0.85
L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors. J Neural Transm (Vienna) (2006) 0.77
Isolation of murine pluripotent hemopoietic stem cells. J Exp Med (1984) 3.56
Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med (1992) 2.12
CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. J Clin Oncol (2003) 1.75
Synaptic biochemistry of amino acids. Fed Proc (1973) 1.74
Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int (1994) 1.66
Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur J Neurosci (1998) 1.51
Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology (2007) 1.47
Successful treatment of Kaposi's sarcoma in a renal allograft recipient. Nephrol Dial Transplant (1995) 1.41
Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Am J Gastroenterol (2011) 1.36
Separation and functional analysis of bone marrow cells separated by rhodamine-123 fluorescence. Exp Hematol (1987) 1.19
Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut (1992) 1.08
Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med (1994) 1.07
Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur J Pharmacol (1990) 1.06
Morphine-induced long-term sensitization to the locomotor effects of morphine and amphetamine depends on the temporal pattern of the pretreatment regimen. Psychopharmacology (Berl) (1997) 1.06
Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia. Mod Pathol (1999) 1.05
Increased dopamine release from rat striatal slices by inhibitors of GABA-aminotransferase. Eur J Pharmacol (1977) 1.05
Thymus regeneration by bone marrow cell suspensions differing in the potential to form early and late spleen colonies. Exp Hematol (1985) 1.02
Release of ACTH by substances of central nervous system origin. Endocrinology (1969) 1.01
Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol (1995) 1.00
ANCA--pathophysiology revisited. Clin Exp Immunol (1995) 0.98
In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab (1993) 0.98
Neurochemical correlates of synaptically active amino acids. Life Sci (1974) 0.97
Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine. Psychopharmacology (Berl) (1999) 0.97
Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus. Cancer Res (1995) 0.96
Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature (1984) 0.96
Transient neurologic and ocular manifestations in primary thrombocythemia. Neurology (1993) 0.96
Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity. Dig Dis Sci (1994) 0.96
Vertebral bone destruction in sickle cell disease: infection, infarction or both. Neth J Med (1996) 0.95
Interferon expression in the testes of transgenic mice leads to sterility. J Biol Chem (1988) 0.93
Adenosine modulates depolarization-induced release of 3H-noradrenaline from slices of rat brain neocortex. Eur J Pharmacol (1978) 0.92
Interacting presynaptic kappa-opioid and GABAA receptors modulate dopamine release from rat striatal synaptosomes. J Neurochem (1993) 0.92
Ethanol, like psychostimulants and morphine, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: possible role in behavioural sensitization. Psychopharmacology (Berl) (1997) 0.92
On the mechanism of alpha-receptor mediated modulation of 3H-noradrenaline release from slices of rat brain neocortex. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.92
Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia. Vaccine (2001) 0.91
Differential control of Ca2+-dependent [3H]noradrenaline release from rat brain slices through presynaptic opiate receptors and alpha-adrenoceptors. Eur J Pharmacol (1983) 0.91
Synergistically interacting dopamine D1 and NMDA receptors mediate nonvesicular transporter-dependent GABA release from rat striatal medium spiny neurons. J Neurosci (2000) 0.91
Release of acetylcholine from hippocampal slices by potassium depolarization: dependence on high affinity choline uptake. Brain Res (1974) 0.91
Effect of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum. Neuropharmacology (1979) 0.91
Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Br J Pharmacol (1997) 0.91
[3H]noradrenaline release from brain slices induced by an increase in the intracellular sodium concentration: role of intracellular calcium stores. J Neurochem (1983) 0.89
Activation of presynaptic alpha-noradrenaline receptors in rat brain by the potent dopamine-mimetic N,N-dipropyl-5,6-ADTN. Eur J Pharmacol (1980) 0.88
Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference. Psychopharmacology (Berl) (1999) 0.88
Cyclic AMP facilitates the electrically evoked release of radiolabelled noradrenaline, dopamine and 5-hydroxytryptamine from rat brain slices. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.88
Correction of lysosomal enzyme deficiency in various organs of beta-glucuronidase-deficient mice by allogeneic bone marrow transplantation. Transplantation (1987) 0.88
Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Eur J Pharmacol (1988) 0.88
Inhibitory effects of histamine on the release of serotonin and noradrenaline from rat brain slices. Neurochem Int (1991) 0.87
Unrestricted free-choice ethanol self-administration in rats causes long-term neuroadaptations in the nucleus accumbens and caudate putamen. Psychopharmacology (Berl) (1999) 0.87
Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group. Gut (1994) 0.86
T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation. Stem Cells (1998) 0.86
Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. Cancer Genet Cytogenet (1996) 0.86
Pharmacological characterization of presynaptic alpha-adrenoceptors modulating [3H]noradrenaline and [3H]5-hydroxytryptamine release from slices of the hippocampus of the rat. Eur J Pharmacol (1982) 0.86
Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Br J Pharmacol (1991) 0.85
Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain. Brain Res Dev Brain Res (1990) 0.85
Modulation by histamine of the efflux of radiolabeled catecholamines from rat brain slices. Eur J Pharmacol (1977) 0.85
Calcium-dependent release of radiolabeled catecholamines and serotonin from rat brain synaptosomes in a superfusion system. Brain Res (1975) 0.85
Effect of mianserin, a potent anti-serotonin agent, on the isolated rat stomach fundus preparation. Eur J Pharmacol (1974) 0.84
Lack of cross-sensitization of the locomotor effects of morphine in amphetamine-treated rats. Neuropsychopharmacology (1999) 0.83
Selectivity of various opioid peptides towards delta-, kappa; and mu-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain. Neuropeptides (1989) 0.83
Mifepristone prevents the expression of long-term behavioural sensitization to amphetamine. Eur J Pharmacol (1996) 0.83
Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: differential long-term effects of intermittent and chronic morphine administration. Neuroscience (1997) 0.83
Potassium-induced release of amino acids from cerebral cortex and spinal cord slices of the rat. Brain Res (1974) 0.83
Evaluation of the benefit of routine intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. ISRN Oncol (2013) 0.83
Effect of surface antigen labeling on spleen colony formation: comparison of the indirect immunofluorescence and the biotin-avidin methods. Exp Hematol (1985) 0.83
MK-801 reinstates drug-seeking behaviour in cocaine-trained rats. Neuroreport (1998) 0.82
On the capacity of presynaptic alpha receptors to modulate norepinephrine release from slices of rat neocortex and the affinity of some agonists and antagonists for these receptors. J Pharmacol Exp Ther (1979) 0.82
Mesangiocapillary glomerulonephritis associated with hereditary angioedema. Nephron (1995) 0.82
A double-blind, placebo-controlled study of monoclonal anti-interleukin-2 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantation. Transplantation (1995) 0.82
Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin. Eur J Pharmacol (1982) 0.82
Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation. Transplantation (1996) 0.82
3H-noradrenaline release from rat neocortical slices in the absence of extracellular Ca2+ and its presynaptic alpha 2-adrenergic modulation. A study on the possible role of cyclic AMP. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.82
Striatal dopamine receptors in rats displaying long-term behavioural sensitization to morphine. Synapse (1997) 0.81
Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices. Eur J Pharmacol (1980) 0.81
Somatostatin analogue scintigraphy of malignant lymphomas. Br J Haematol (1993) 0.81
Right hemothorax: An unusual presentation of a Barrett's ulcer perforation. Int J Surg Case Rep (2013) 0.81
Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering mu-opioid receptor sensitivity. Life Sci (1993) 0.81
Morphine and enkephalins potently inhibit [3H]noradrenaline release from rat brain cortex synaptosomes: further evidence for a presynaptic localization of mu-opioid receptors. J Neurochem (1987) 0.81
Opioid receptor-mediated inhibition of 3H-dopamine and 14C-acetylcholine release from rat nucleus accumbens slices. A study on the possible involvement of K+ channels and adenylate cyclase. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.81
Noradrenaline inhibits depolarization-induced 3H-serotonin release from slices of rat hippocampus. Eur J Pharmacol (1980) 0.80
Muscarine receptor-mediated modulation of [3H]dopamine and [14C]acetylcholine release from rat neostriatal slices: selective antagonism by gallamine but not pirenzepine. Eur J Pharmacol (1986) 0.80
Cyclic AMP and alpha-receptor-mediated modulation of noradrenaling release from rat brain slices. Eur J Pharmacol (1976) 0.80
Release and receptor stimulating properties of p-tyramine in rat brain. Arch Int Pharmacodyn Ther (1976) 0.80
Alpha-receptor-mediated modulation of 3H-noradrenaline release from rat brain cortex synaptosomes. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.80
On the presence of a MSH-release inhibiting system in the rat neurointermediate lobe. Neuroendocrinology (1975) 0.80
Pharmacological characterization of presynaptic alpha-adrenoceptors in the nucleus tractus solitarii and the cerebral cortex of the rat. Neuropharmacology (1982) 0.80
Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation. Eur J Pharmacol (1994) 0.80
Opposing role of dopamine D1 and D2 receptors in modulation of rat nucleus accumbens noradrenaline release. J Neurosci (1999) 0.80
Histaminergic projections from the premammillary and posterior hypothalamic region to the caudate-putamen complex in the rat. Brain Res (1986) 0.80
3H-Noradrenaline and 3H-5-hydroxytryptamine release from rat brain slices and its presynaptic alpha-adrenergic modulation after long-term desipramine pretreatment. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.80
Identification of MSH release-inhibiting elements in the neurointermediate lobe of the rat. Brain Res (1979) 0.80
IL-1/IL-3 gene therapy of non-small cell lung cancer (NSCLC) in rats using 'cracked' adenoproducer cells. Gene Ther (1998) 0.80
Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors. J Pharmacol Exp Ther (1991) 0.80
Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors. J Neurosci (1986) 0.80
An overview of subcellular localization, release and termination of action of amine, amino acid and peptide neurotransmitters in the central nervous system. Prog Brain Res (1982) 0.79
Adrenocorticotropin/alpha-melanocyte-stimulating hormone (ACTH/MSH)-like peptides modulate adenylate cyclase activity in rat brain slices: evidence for an ACTH/MSH receptor-coupled mechanism. J Neurochem (1993) 0.79
The role of molecular analysis of immunoglobulin and T cell receptor gene rearrangements in the diagnosis of lymphoproliferative disorders. J Clin Pathol (2001) 0.79
GABA modulates the release of dopamine and acetylcholine from rat caudate nucleus slices. Eur J Pharmacol (1979) 0.79